Chan Kk
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Insect Resistance and Genetics 3
- RNA Interference and Gene Delivery 2
- Metabolism, Diabetes, and Cancer 2
- Cancer therapeutics and mechanisms 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 4
- Co-authors
- G. Blackledge (2 shared papers)Chlebowski Rt (2 shared papers)Eric Watson (2 shared papers)Mark Tong (1 shared paper)Block Jb (1 shared paper)Bateman (1 shared paper)Anderson (1 shared paper)Wah‐Kheong Chan (1 shared paper)
- Journals
- Antarctic Science (1 paper)The Pharmacogenomics Journal (1 paper)Journal of the American Chemical Society (1 paper)Journal of Cellular and Molecular Medicine (1 paper)Small (1 paper)
- Partner nations
- MalaysiaUnited KingdomTaiwan
In The Last Decade
Chan Kk
25 papers receiving 571 citations
Peers
Comparison fields: 5 of 89
- Reproductive Medicine 131
- Hepatology 71
- Oncology 153
- Obstetrics and Gynecology 41
- Otorhinolaryngology 20
Countries citing papers authored by Chan Kk
This map shows the geographic impact of Chan Kk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chan Kk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chan Kk more than expected).
Fields of papers citing papers by Chan Kk
This network shows the impact of papers produced by Chan Kk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chan Kk. The network helps show where Chan Kk may publish in the future.
Co-authors
The 25 scholars most cited alongside Chan Kk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results. | 1984 | 93 |
| 2 | Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer. | 1989 | 91 |
| 3 | Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. | 1978 | 74 |
| 4 | Proliferation and cell death in oligodendrogliomas. | 1998 | 41 |
| 5 | The CSROC Expert Panel. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy | 2010 | 39 |
| 6 | Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols. | 1973 | 39 |
| 7 | Second-look laparotomy in the management of epithelial ovarian carcinoma: an evaluation of fifty cases. | 1984 | 32 |
| 8 | 2005 | 29 | |
| 9 | Effects of tocotrienols on cell viability and apoptosis in normal murine liver cells (BNL CL.2) and liver cancer cells (BNL 1ME A.7R.1), in vitro. | 2005 | 28 |
| 10 | 2020 | 22 | |
| 11 | Selective cytotoxic activity against leukemic cell lines from mosquitocidal Bacillus thuringiensis parasporal inclusions. | 2008 | 22 |
| 12 | Rapid analytic method for adriamycin and metabolites in human plasma by a thin-film fluorescence scanner. | 1976 | 22 |
| 13 | Metabolism of methotrexate in man after high and conventional doses. | 1980 | 16 |
| 14 | High-presssure liquid chromatographic determination of methotrexate and its major metabolite, 7-hydroxymethotrexate, in human plasma. | 1978 | 14 |
| 15 | A fluorometric determination of adriamycin and its metabolites in biological tissues. | 1973 | 10 |
| 16 | A pilot study on early post-operative morbidity and technique of inguinal node dissection in vulval carcinoma. | 1998 | 9 |
| 17 | Survival after negative second-look laparotomy. | 1989 | 8 |
| 18 | 2012 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2025 | 5 |
About Chan Kk
Chan Kk is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 623 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Insect Resistance and Genetics (3 papers), Cancer Treatment and Pharmacology (3 papers), Acute Lymphoblastic Leukemia research (3 papers), RNA Interference and Gene Delivery (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Reproductive Medicine (131 citations), Hepatology (71 citations), Oncology (153 citations), Obstetrics and Gynecology (41 citations) and Otorhinolaryngology (20 citations). Chan Kk has collaborated with scholars based in Malaysia, United Kingdom and Taiwan. Frequent co-authors include G. Blackledge, Chlebowski Rt, Eric Watson, Mark Tong, Block Jb, Bateman, Anderson, Wah‐Kheong Chan, Stephen B. Wharton and Vishna Devi Nadarajah. Their work appears in journals such as Antarctic Science, The Pharmacogenomics Journal, Journal of the American Chemical Society, Journal of Cellular and Molecular Medicine and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.